Premium
Convalescent donor SARS‐COV‐2‐specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID‐19 patients with severe disease has not received enough attention till date
Author(s) -
Hanley Brian,
Roufosse Candice A.,
Osborn Michael,
Naresh Kikkeri N.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16780
Subject(s) - medicine , disease , immunology , cd8 , cytotoxic t cell , pneumonia , lymphocyte , virus , lymphocytopenia , virology , immune system , pathology , biology , biochemistry , in vitro
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom